The Longwood Healthcare Leaders Meeting & Conference 2027
A healthcare leadership meeting and conference bringing together biotech and pharmaceutical executives, research leaders, academics, and life science investors.
Four Seasons Hotel San Francisco
- Date
- January 9, 2027
- Venue
- Four Seasons Hotel San Francisco
- Location
- San Francisco, CA
TL;DR
- The 2027 meeting starts January 9 at Four Seasons Hotel San Francisco in San Francisco, California.
- The organizer describes an audience that includes biotech and pharmaceutical CEOs, R&D leaders, healthcare academics, and life science investors.
- Its stated format is intended to support confidential discussion and collaboration among participants.
About
Longwood Healthcare Leaders convenes biotech and pharmaceutical executives, research leaders, healthcare academics, and life science investors. The meetings are intended to create space for candid discussion and collaboration, with the broader aim of helping translate discoveries into medicines that improve patient outcomes.
Who you'll find in the room
Biotech and pharmaceutical CEOs
The organizer identifies senior biotech and pharmaceutical company executives among the meeting's audience.
R&D leaders
Research and development heads are part of the stated audience.
Healthcare academics
The organizer also identifies healthcare academics as attendees.
Life science investors
Life science investors are included in the audience description.
Featured speakers
76 listedRobert Califf
former Commissioner FDA
Julie Gerberding
CEO, Foundation for the NIH former Director, CDC
Steve Hahn
CEO, Harbinger Health
former Commissioner, FDA
Peggy Hamburg
Former Commissioner FDA
Maura Healey
Governor Commonwealth of Massachusetts
Edward J. Markey
Senator Commonwealth of Massachusetts
Paul Markovich
CEO Blue Shield California
Peter Marks
former Director, CBER, FDA SVP, Molecule Discovery, Lilly
Rochelle Walensky
Director CDC (2021-2023)
Janet Woodcock
former Acting Commissioner FDA
Bill Anderson
CEO Bayer
Stephane Bancel
CEO Moderna
Hal Barron
CEO Altos Labs
Marianne De Backer
CEO Vir Bio
Teresa Graham
CEO Roche Pharma
Yvonne Greenstreet
CEO Alnylam
Alexander Hardy
CEO Biomarin
Ken Keller
CEO Daiichi Sankyo, Inc.
David Lee
CEO Servier Pharmaceuticals
Jeremy Levin
CEO Ovid Therapeutics
David Loew
CEO Ipsen
John Maraganore
former CEO Alnylam
Paul McKenzie
CEO CSL
Stefan Oelrich
CEO Bayer Pharma
Tarek Rabah
CEO Otsuka NA
Dave Ricks
Chair & CEO Eli Lilly
Brent Saunders
CEO Bausch + Lomb
Thomas Schinecker
CEO Roche
Chris Viehbacher
CEO Biogen
Christophe Weber
CEO Takeda
Eliav Barr
CMO Merck
Sharon Barr
EVP, BioPharmaceuticals R&D AstraZeneca
Jay Bradner
SVP, R&D, & CSO Amgen
Levi Garraway
CMO Genentech Roche
Jane Grogan
EVP, Head, Research Biogen
Dean Li
President Merck
Fiona Marshall
President, Biomedical Research Novartis
Bill Mezzanotte
Global Head, R&D & CMO CSL
Karen Nelson
CSO Thermo Fisher Scientific
Robert Plenge
Chief Research Officer BMS
Andy Plump
President, R&D Takeda
John Reed
EVP, Pharma R&D Johnson & Johnson
Dave Reese
CTO Amgen
Aviv Regev
EVP, Research & Early Development Genentech
Christian Rommel
Global Head, R&D Bayer Pharma
Marcus Schindler
CSO Novo Nordisk
Priya Singhal
EVP & Head, Development Biogen
Daniel Skovronsky
CSO Eli Lilly
Tadaaki Taniguchi
Chief R&D Officer Astellas
George Yancopoulos
President & CSO Regeneron
Vanessa Broadhurst
Executive Vice President, Global Corporate Affairs Johnson & Johnson
Miguel Fernández Alcalde
President EMD Serono
Nouhad Husseini
SVP, BD Regeneron
Rachna Khosla
SVP, BD Amgen
Stu Mackey
Global Head, BD Daiichi Sankyo
Aamir Malik
CBIO Pfizer
Dave Moore
President Novo Nordisk Inc.
David Redfern
President, Corporate Development GSK
Aradhana Sarin
CFO AstraZeneca
Nauman Shah
Global Head, BD Janssen
Carolyn Bertozzi
Professor of Chemistry Stanford University
Sangeeta Bhatia
Director, Marble Center for Cancer Nanomedicine Koch Institute at MIT
George Daley
Dean Harvard Medical School
Ben Ebert
CEO Dana-Farber Cancer Institute
Victor Dzau
President National Academy of Medicine
Alan Garber
President Harvard University
Susan Hockfield
President Emerita MIT
Bill Kaelin
Sidney Farber Professor of Medicine Dana-Farber Cancer Institute
Anne Klibanski
President & CEO Mass General Brigham
Sally Kornbluth
President MIT
Bob Langer
Institute Professor MIT
David Liu
Vice-Chair of Faculty The Broad Institute, MIT
Lloyd Minor
Dean Stanford School of Medicine
Phil Sharp
Institute Professor, MIT Co-Founder, Biogen/Alnylam
Tim Springer
Latham Family Professor Harvard Medical School
Venue & travel
Venue
Four Seasons Hotel San FranciscoQuestions people ask
5 answeredThe 2027 meeting starts January 9.
The 2027 meeting is at Four Seasons Hotel San Francisco in San Francisco, California.
The stated audience includes biotech and pharmaceutical CEOs, R&D heads, healthcare academics, and life science investors.
It is most worth attending for biotech and pharma executives, R&D heads and life science investors who value off-the-record conversation with senior figures, since the speaker list includes the CEOs of Moderna, Bayer and Roche Pharma alongside former FDA commissioners Robert Califf and Janet Woodcock. Early-career scientists, vendors and anyone seeking a broad open exhibition or technical workshops will get less from it, as the format is a closed, invitation-style leadership meeting at the Four Seasons Hotel San Francisco.
Executives and investors at leadership meetings in a Four Seasons hotel usually wear business attire, such as suits or blazers with open collars, with San Francisco's cool January weather calling for a light overcoat.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in